Canada

Biopharma bites: Ozempic's impact on kidney disease, OliX's raise and UK support for AbbVie's Elahere – FirstWord Pharma

  1. Biopharma bites: Ozempic’s impact on kidney disease, OliX’s raise and UK support for AbbVie’s Elahere  FirstWord Pharma
  2. Ozempic Eased Daily Burdens of Diabetes and Kidney Disease in New Trial  Everyday Health